Videos de Experimentos Relacionados
Programas de tratamiento de la tuberculosis.
Lancet (London, England)
|August 27, 1994
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Multidrug-resistant tuberculosis in the United Kingdom and Lithuania.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2014
Same author
Rapid molecular detection of tuberculosis and rifampicin drug resistance: retrospective analysis of a national U.K. molecular service over the last decade.
Thorax·2012
Same author
Human Mycobacterium bovis infections in London and Southeast England.
Journal of clinical microbiology·2011
Same author
Multidrug-resistant tuberculosis: resistance rates to first and reserve antituberculosis drugs in the UK in 2008/9 and the role of rapid molecular tests for drug resistance.
Thorax·2010
Same author
Typing Mycobacterium tuberculosis using variable number tandem repeat analysis.
Methods in molecular biology (Clifton, N.J.)·2010
Same author
The added value of a European Union tuberculosis reference laboratory network--analysis of the national reference laboratory activities.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2008
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026
Same journal
Dual mobility total hip replacement in fractures: stability promotes patient confidence.
Lancet (London, England)·2026